However, in the current analyses, the opposite could be demonstrated: tumor samples demonstrating Δ133p53α had smaller tumor sizes and not advanced sizes as could be expected if Δ133p53α would be an inhibitor of senescence, apoptosis, and p53 transcriptional activity. The gene discussed is TP53; the disease is neoplasm.